Risk factor
Very poor trading liquidity
Profitability factor
Undervalued vs peers
About
Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells medicine and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis uses. The company's principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the...
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'cheap' on EV/EBITDA,
Target Price
The average target price of 003220.KS is 19000 and suggests 86% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to
Buy
Sell